FY2025 EPS Forecast for Canopy Growth Lowered by Analyst

Market Beat
2025.06.02 05:50

Roth Capital has lowered its FY2025 earnings estimates for Canopy Growth Co. (NASDAQ:CGC) to ($1.96) per share, down from ($1.89). The consensus estimate for the company's current full-year earnings is ($2.81) per share. Additionally, Piper Sandler reiterated an "underweight" rating on the stock. Canopy Growth's shares opened at $1.32, with a 12-month low of $0.77 and a high of $8.68. The company reported ($0.94) EPS for the last quarter, missing estimates significantly.

  • Constellation Brands: A Fallen Star or a Hidden Value Play?

Canopy Growth Co. (NASDAQ:CGC - Free Report) - Equities researchers at Roth Capital lowered their FY2025 earnings estimates for shares of Canopy Growth in a report issued on Wednesday, May 28th. Roth Capital analyst W. Kirk now forecasts that the company will earn ($1.96) per share for the year, down from their prior forecast of ($1.89). The consensus estimate for Canopy Growth's current full-year earnings is ($2.81) per share. Roth Capital also issued estimates for Canopy Growth's Q4 2025 earnings at ($0.12) EPS.

Get Canopy Growth alerts:

Separately, Piper Sandler reiterated an "underweight" rating on shares of Canopy Growth in a research note on Friday.

  • Profit from the Green Wave: Top Cannabis Stocks to Watch

Get Our Latest Research Report on Canopy Growth

Canopy Growth Price Performance

Shares of NASDAQ:CGC opened at $1.32 on Monday. The company's fifty day moving average price is $1.28 and its 200 day moving average price is $2.00. Canopy Growth has a 12 month low of $0.77 and a 12 month high of $8.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 3.52 and a quick ratio of 2.58. The firm has a market capitalization of $241.78 million, a P/E ratio of -0.35 and a beta of 0.79.

  • MarketBeat Week in Review – 8/12 - 8/16

Canopy Growth (NASDAQ:CGC - Get Free Report) last announced its quarterly earnings results on Friday, May 30th. The company reported ($0.94) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.66). Canopy Growth had a negative return on equity of 56.52% and a negative net margin of 156.98%. The company had revenue of $45.30 million for the quarter, compared to analyst estimates of $71.84 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Concurrent Investment Advisors LLC grew its position in Canopy Growth by 26.6% during the 4th quarter. Concurrent Investment Advisors LLC now owns 24,644 shares of the company's stock worth $68,000 after purchasing an additional 5,172 shares during the last quarter. Jones Financial Companies Lllp grew its position in Canopy Growth by 222.9% during the 4th quarter. Jones Financial Companies Lllp now owns 9,315 shares of the company's stock worth $26,000 after purchasing an additional 6,430 shares during the last quarter. Apollon Wealth Management LLC purchased a new position in Canopy Growth during the 4th quarter worth $38,000. OLD Mission Capital LLC grew its position in Canopy Growth by 41.6% during the 4th quarter. OLD Mission Capital LLC now owns 51,066 shares of the company's stock worth $140,000 after purchasing an additional 15,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP purchased a new position in Canopy Growth during the 4th quarter worth $41,000. 3.33% of the stock is owned by hedge funds and other institutional investors.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Featured Stories

  • Five stocks we like better than Canopy Growth
  • How to Use the MarketBeat Dividend Calculator
  • Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet
  • Should You Add These Warren Buffett Stocks to Your Portfolio?
  • e.l.f. Gets Back on the Shelf! It’s Not Too Late to Buy In!
  • Stock Market Upgrades: What Are They?
  • Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.